Literature DB >> 17955311

Endoscopic ultrasound and computed tomography predictors of pancreatic cancer resectability.

Philip Q Bao1, J Chad Johnson, Elizabeth H Lindsey, David A Schwartz, Ron C Arildsen, Ewa Grzeszczak, Alexander A Parikh, Nipun B Merchant.   

Abstract

INTRODUCTION: This study investigates the ability of endoscopic ultrasound (EUS) and computed tomography (CT) to predict a margin negative (R0) resection and the need for venous resection in patients undergoing pancreaticoduodenectomy (PD).
METHODS: Patients with pancreatic head adenocarcinoma undergoing surgery with intent to resect during the last 5 years were identified. EUS and CT data on vascular involvement were collected. Preoperative imaging was compared to intraoperative findings and final pathology. Contingency table analysis using Fisher's exact test identified imaging features of EUS and CT associated with unresectability and positive margins.
RESULTS: Seventy-six patients met study criteria. Forty-seven (62%) underwent potentially curative PD. The R0 resection rate was 70%. There were 16 unresectable patients because of locally advanced disease. Venous involvement>180 degrees and arterial involvement>90 degrees by CT had 100% positive predictive value for failure to achieve R0 resection (p<.01). If patients with prestudy biliary stents were excluded, EUS venous abutment or invasion also predicted R0 failure (p=.02). Combined but not individual EUS and CT findings were predictive of need for vein resection.
CONCLUSIONS: Pancreas protocol CT imaging appears to be a better predictor of resectability compared to EUS. EUS accuracy is affected by the presence of biliary stents.

Entities:  

Mesh:

Year:  2007        PMID: 17955311     DOI: 10.1007/s11605-007-0373-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  16 in total

1.  Preoperative assessment of pancreatic malignancy using endoscopic ultrasound.

Authors:  I F Yusoff; R M Mendelson; S E J Edmunds; D Ramsay; G L Cullingford; D R Fletcher; A M J Zimmerman
Journal:  Abdom Imaging       Date:  2003 Jul-Aug

2.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

3.  Pancreatic adenocarcinoma: signs of vascular invasion determined by multi-detector row CT.

Authors:  H Li; M S Zeng; K R Zhou; D Y Jin; W H Lou
Journal:  Br J Radiol       Date:  2006-07-05       Impact factor: 3.039

4.  A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

Authors:  Thomas J Howard; Joseph E Krug; Jian Yu; Nick J Zyromski; C Max Schmidt; Lewis E Jacobson; James A Madura; Eric A Wiebke; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

5.  EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates.

Authors:  Harry Aslanian; Ronald Salem; Jeffrey Lee; Dana Andersen; Marie Robert; Mark Topazian
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

6.  CT criteria for venous invasion in patients with pancreatic head carcinoma.

Authors:  S S Phoa; J W Reeders; J Stoker; E A Rauws; D J Gouma; J S Laméris
Journal:  Br J Radiol       Date:  2000-11       Impact factor: 3.039

7.  Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography.

Authors:  Antonio Soriano; Antoni Castells; Carmen Ayuso; Juan Ramón Ayuso; Maria Teresa de Caralt; Maria Angels Ginès; Maria Isabel Real; Rosa Gilabert; Llorenç Quintó; Antoni Trilla; Faust Feu; Xavier Montanyà; Laureano Fernández-Cruz; Salvador Navarro
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

8.  Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound.

Authors:  Susannah Yovino; Peter Darwin; Barry Daly; Michael Garofalo; Robert Moesinger
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

Review 9.  Current status of radical systematic lymphadenectomy in pancreatic cancer--a review of the literature.

Authors:  Matthias Peiper; E Bölke; K Orth; S B Hosch; A Rehders; H Matthaei; W T Knoefel
Journal:  Eur J Med Res       Date:  2007-02-26       Impact factor: 2.175

10.  Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer.

Authors:  John DeWitt; Benedict Devereaux; Melissa Chriswell; Kathleen McGreevy; Thomas Howard; Thomas F Imperiale; Donato Ciaccia; Kathleen A Lane; Dean Maglinte; Kenyon Kopecky; Julia LeBlanc; Lee McHenry; James Madura; Alex Aisen; Harvey Cramer; Oscar Cummings; Stuart Sherman
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

View more
  13 in total

1.  Impact of biliary stents on EUS-guided FNA of pancreatic mass lesions.

Authors:  Nathaniel Ranney; Milind Phadnis; Jessica Trevino; Jayapal Ramesh; C Mel Wilcox; Shyam Varadarajulu
Journal:  Gastrointest Endosc       Date:  2012-07       Impact factor: 9.427

Review 2.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

3.  Preoperative radiographic vascular involvement score predicts the prognosis of resected pancreatic head adenocarcinoma.

Authors:  Shunsuke Onoe; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Yasuyuki Fukami
Journal:  Langenbecks Arch Surg       Date:  2017-03-01       Impact factor: 3.445

Review 4.  Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review.

Authors:  RenBao Yang; ManPeng Lu; XiaoXing Qian; Jiong Chen; Liang Li; JiaWen Wang; YouQian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-11       Impact factor: 4.553

5.  Comparison of the influence of plastic and fully covered metal biliary stents on the accuracy of EUS-FNA for the diagnosis of pancreatic cancer.

Authors:  Ali A Siddiqui; Michael Fein; Thomas E Kowalski; David E Loren; Mohamad A Eloubeidi
Journal:  Dig Dis Sci       Date:  2012-04-21       Impact factor: 3.199

6.  Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma.

Authors:  Philip Bao; Douglas Potter; David P Eisenberg; Diana Lenzner; Herbert J Zeh; Kenneth Kw Lee Iii; Steven J Hughes; Michael K Sanders; Jennifer L Young; A James Moser
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

7.  Lower yield of endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic head mass with a biliary stent.

Authors:  John J Kim; Sukhpreet Walia; Scott H Lee; Bhavesh Patel; Madhavi Vetsa; Yan Zhao; Wichit Srikureja; Loren Laine
Journal:  Dig Dis Sci       Date:  2014-09-23       Impact factor: 3.199

8.  Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms.

Authors:  Tara S Kent; Vassilios Raptopoulos; Mark P Callery; Shiva Gautam; Charles M Vollmer
Journal:  HPB (Oxford)       Date:  2010-03       Impact factor: 3.647

9.  Vascular resection in pancreatic adenocarcinoma with portal or superior mesenteric vein invasion.

Authors:  Gang Pan; Kun-Lin Xie; Hong Wu
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

10.  CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma.

Authors:  Peng Liu; Yuan Zhu; Luying Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.